Browse > Article
http://dx.doi.org/10.5478/MSL.2020.11.1.10

Liquid Chromatography-Tandem Mass Spectrometry Analysis of Riboflavin in Beagle Dog Plasma for Pharmacokinetic Studies  

Jeong, Hyeon Myeong (School of Pharmacy, Sungkyunkwan University)
Shin, Beom Soo (School of Pharmacy, Sungkyunkwan University)
Shin, Soyoung (Department of Pharmacy, College of Pharmacy, Wonkwang University)
Publication Information
Mass Spectrometry Letters / v.11, no.1, 2020 , pp. 10-14 More about this Journal
Abstract
Riboflavin is a water-soluble vitamin, which serves as a precursor to flavin mononucleotide and flavin adenine dinucleotide. This study aimed to develop a simple and rapid liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis for the quantification of riboflavin in the Beagle dog plasma. This method utilized simple protein precipitation with acetonitrile and 13C4, 15N2-riboflavin was used as an internal standard (IS). For chromatographic separation, a hydrophilic interaction liquid chromatography (HILIC) column was used with gradient elution. The mobile phase consisted of 0.1% (v/v) aqueous formic acid with 10 mM ammonium formate and acetonitrile with 0.1% (v/v) formic acid. Since riboflavin is an endogenous compound, 4% bovine serum albumin in phosphate buffered saline was used as a surrogate matrix to prepare the calibration curve. The quantification limit for riboflavin in the Beagle dog plasma was 5 ng/mL. The method was fully validated for its specificity, sensitivity, accuracy and precision, recovery, and stability according to the US FDA guidance. The developed LC-MS/MS method may be useful for the in vivo pharmacokinetic studies of riboflavin.
Keywords
riboflavin; LC-MS/MS; validation; plasma; Beagle dog;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Pinto, J.; Rivlin, R. Riboflavin (Vitamin B2). In Handbook of Vitamins, 5th ed., CRC press: Boca Raton 2013, 191.
2 Depeint, F.; Bruce, W. R.; Shangari, N.; Mehta, R.; O'Brien, P. J. Chem. Biol. Interact. 2006, 163, 94.   DOI
3 Du, L.; Li, G.; Jin, Y.; Wang, L.; Xu, Q.; Dong, J. Int. J. Pharm. 2013, 450, 338.   DOI
4 Levy, G.; Jusko, W. J. J. Pharm. Sci. 1966, 55, 285.   DOI
5 Christensen, S. Acta Pharmacol. Toxicol. 1973, 32, 3.
6 Kagan, L.; Lapidot, N.; Afargan, M.; Kirmayer, D.; Moor, E.; Mardor, Y.; Friedman, M.; Hoffman, A. J. Control. Release 2006, 113, 208.   DOI
7 Ahmed, I. S.; Ayres, J. W. Int. J. Pharm. 2007, 330, 146.   DOI
8 Rocha, F. R.; Fatibello Filho, O.; Reis, B. F. Talanta 2003, 59, 191.   DOI
9 Heudi, O.; Kilinc, T.; Fontannaz, P. J. Chromatogr. A 2005, 1070, 49.   DOI
10 Petteys, B. J.; Frank, E. L. Clin. Chim. Acta 2011, 412, 38.   DOI
11 Diniz, M.; Dias, N.; Andrade, F.; Paulo, B.; Ferreira, A. J. Chromatogr. B 2019, 1113, 14.   DOI
12 FDA U. S. Analytical Procedures and Methods Validation for Drugs and Biologics, FDA U. S.: Silver Spring, MD, 2015.
13 Thapa, S. K.; Weon, K. Y.; Jeong, S. W.; Kim, T. H.; Upadhyay, M.; Han, Y. H.; Jin, J. S.; Hong, S. H.; Youn, Y. S.; Shin, B.; Shin, S. Mass Spectrom. Lett. 2017, 8, 23.   DOI
14 Thapa, S. K.; Upadhyay, M.; Kim, T. H.; Shin, S.; Park, S.-J.; Shin, B. S. Molecules 2019, 24, 2037.   DOI